• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

A Breast Cancer Diagnosis in the Interval Between Mammograms: Who is at Risk?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Interval cancers are those that are diagnosed after receiving a ‘negative screen’ mammography report, but before the next recommended screening examination
  • 15% of breast cancers are ‘interval cancers’ and include
    • Cancers that were missed on the initial ‘negative screen’
    • Rapid growing cancers that were not present on the initial screen and present due to symptoms (e.g. detecting a lump) which tend to be poorer prognosis
    • McCarthy et al. (JAMA Oncology, 2018) sought to identify women who were at higher risk for a poor prognosis (latter group) with interval cancer

METHODS:

  • Mammogram data was collected from the Population-Based Research Optimizing Screening Through Personalized Regimens (PROSPR) consortium
  • Participants: Women ≥40 years with no earlier diagnosis of breast cancer who received screening mammography and negative screening results (BI-RADS 1 or 2)
  • Cancer diagnoses within 1 year after screening mammography were obtained from state cancer registries
  • Poor prognosis breast cancers were defined as
    • Distant metastases | Cancer-positive regional lymph nodes | Estrogen receptor–positive and/or progesterone receptor–positive and HER2-negative invasive cancer 2 cm or more in diameter | Eestrogen receptor–negative, progesterone receptor–negative, HER2-negative (triple-negative) invasive cancer 1 cm or more in diameter | HER2-positive invasive cancer 1 cm or more in diameter
  • Association of age, breast density, and family history with cancer diagnosis was assessed using logistic regression analysis

RESULTS:

  • 306,028 women were included in the study
    • 272,881 women had a negative screening result
    • Only 160 women (5.9 per 10,000) had a cancer within 1 year of negative screening mammography
  • Interval cases were more likely to have poor prognosis compared to positive mammography cases (43.8% v. 26.9% )
  • Among all women with negative mammography results
    • Women with dense breasts were twice as likely to receive a cancer diagnosis vs nondense breasts (odds ratio [OR] of 2.07; 95% CI,1.48-2.89 (P = .02)
    • Age and family history were not associated with greater likelihood of cancer diagnosis
  • Among those with interval breast cancer, younger women (40-49 years) were more likely to receive poor prognosis than older women (70-89 years)
    • OR of 3.52; 95% CI, 1.15-10.72; (P= .048; P for trend = .005)
  • Breast density and family history were not associated with poor prognosis interval cancers
  • In cases with positive mammogram results, positive predictive value for subsequent cancer diagnosis depended on older patient age and positive family history but not breast density
    • 40-49 years vs those 70-89 years: OR, 0.22; 95% CI, 0.18-0.26 (P < .001)
    • Positive family history: OR, 1.29; 95% CI, 1.12-1.48 (P < .001)
    • None of these factors were associated with poor prognosis

CONCLUSION:

  • The chance of having an interval cancer is small but more likely to be associated with a poor prognosis
  • Breast density is predictive of an interval cancer but not whether the cancer will have a poor prognosis
  • Younger women were more at risk to receive a poor prognosis with an interval cancer than older women
    • More likely to be rapidly growing vs slower growing cancers that are more typically seen in older women
  • While breast density increases breast cancer risk, including other factors such as age may be helpful in identifying women at higher risk for poor prognosis interval breast cancer

Learn More – Primary Sources:

Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative Results

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Office Evaluation of Breast Disorders
BI-RADS: Standardizing Breast Imaging and Reporting 
Has Breast Density Legislation Had Any Impact on Breast Cancer Diagnosis? 
Prophylactic Mastectomy and BRCA – Risk Reduction and Guidelines
How Effective Is Mammography in Reducing the Number of Advanced Breast Cancer Diagnoses?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site